Oxular appoints Dr. Friedrich Asmus as CMO

Dr. Asmus brings two decades of experience leading global clinical and translational research programs for both retinal and rare diseases. OXFORD, UK, 7 June 2021 – Oxular Limited (“Oxular”), a leading retinal therapeutics development company, today announces it has appointed Dr. Friedrich (Fritz) Asmus as Chief Medical Officer. Dr. Asmus will lead all medical, clinical, …

Oxular appoints Dr. Friedrich Asmus as CMO Read More »